COLORECTAL CANCER RECURRENT

This adverse event was reported 129 times

These drugs are most commonly taken by patients reporting COLORECTAL CANCER RECURRENT:

# Drug Count
0 PANITUMUMAB 37
1 BEVACIZUMAB 32
2 OXALIPLATIN 24
3 FLUOROURACIL 23
4 FLUOROURACIL CREAM, 0.5% 23
5 FRUQUINTINIB 13
6 REGORAFENIB 13
7 CAPECITABINE 11
8 DARATUMUMAB 7
9 DEXAMETHASONE 7
See all common drugs associated with COLORECTAL CANCER RECURRENT

COLORECTAL CANCER RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FRUQUINTINIB 13 0.0033
1 PANITUMUMAB 37 0.0023
2 DIFLUPREDNATE OPHTHALMIC 1 0.0011
3 REGORAFENIB 13 0.0011
4 WHITE PETROLATUM 1 0.0007
5 FLURBIPROFEN 1 0.0007
6 TRIFLURIDINE AND TIPIRACIL 7 0.0006
7 NALDEMEDINE 1 0.0006
8 SKIN PROTECTANT 1 0.0004
9 OXALIPLATIN 24 0.0003
See all drugs enriched for association with COLORECTAL CANCER RECURRENT